| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | peptide lactyltransferase (CoA-dependent) activity | 1.43e-05 | 2 | 76 | 2 | GO:0120300 | |
| GeneOntologyMolecularFunction | histone H3K27 acetyltransferase activity | 1.43e-05 | 2 | 76 | 2 | GO:0044017 | |
| GeneOntologyMolecularFunction | histone H3K18 acetyltransferase activity | 4.28e-05 | 3 | 76 | 2 | GO:0043993 | |
| GeneOntologyBiologicalProcess | regulation of maintenance of sister chromatid cohesion | 5.66e-06 | 10 | 76 | 3 | GO:0034091 | |
| GeneOntologyBiologicalProcess | maintenance of sister chromatid cohesion | 1.70e-05 | 14 | 76 | 3 | GO:0034086 | |
| GeneOntologyBiologicalProcess | regulation of sister chromatid cohesion | 5.24e-05 | 20 | 76 | 3 | GO:0007063 | |
| GeneOntologyBiologicalProcess | N-terminal peptidyl-lysine acetylation | 8.00e-05 | 4 | 76 | 2 | GO:0018076 | |
| GeneOntologyCellularComponent | condensed chromosome, centromeric region | 6.55e-06 | 193 | 76 | 7 | GO:0000779 | |
| GeneOntologyCellularComponent | condensed chromosome | 1.57e-05 | 307 | 76 | 8 | GO:0000793 | |
| GeneOntologyCellularComponent | chromosomal region | 2.16e-05 | 421 | 76 | 9 | GO:0098687 | |
| GeneOntologyCellularComponent | chromosome, centromeric region | 6.51e-05 | 276 | 76 | 7 | GO:0000775 | |
| GeneOntologyCellularComponent | ciliary transition zone | 2.17e-04 | 81 | 76 | 4 | GO:0035869 | |
| GeneOntologyCellularComponent | nuclear body | NELFE ATRX CENPC SLF2 CCNB3 RBM4 AHCTF1 SCAPER SGO2 TRIP12 CREBBP | 4.03e-04 | 903 | 76 | 11 | GO:0016604 |
| GeneOntologyCellularComponent | ciliary tip | 7.10e-04 | 48 | 76 | 3 | GO:0097542 | |
| GeneOntologyCellularComponent | sperm midpiece | 1.64e-03 | 64 | 76 | 3 | GO:0097225 | |
| HumanPheno | Polydactyly | ZNF141 AHI1 EVC2 TRAF3IP1 DYNC2H1 VPS35L SCAPER CREBBP EP300 SLX4 | 2.04e-06 | 340 | 25 | 10 | HP:0010442 |
| HumanPheno | Shawl scrotum | 5.33e-06 | 25 | 25 | 4 | HP:0000049 | |
| HumanPheno | Plantar crease between first and second toes | 2.31e-05 | 2 | 25 | 2 | HP:0008107 | |
| HumanPheno | Aortic isthmus hypoplasia | 2.31e-05 | 2 | 25 | 2 | HP:0034227 | |
| HumanPheno | High axial triradius | 2.31e-05 | 2 | 25 | 2 | HP:0001042 | |
| HumanPheno | Nephronophthisis | 2.67e-05 | 37 | 25 | 4 | HP:0000090 | |
| HumanPheno | Duplication involving bones of the feet | 5.87e-05 | 147 | 25 | 6 | HP:0009136 | |
| HumanPheno | Foot polydactyly | 5.87e-05 | 147 | 25 | 6 | HP:0001829 | |
| HumanPheno | Laryngeal cartilage malformation | 6.92e-05 | 3 | 25 | 2 | HP:0008752 | |
| HumanPheno | Phobia | 6.92e-05 | 3 | 25 | 2 | HP:5200232 | |
| HumanPheno | Agoraphobia | 6.92e-05 | 3 | 25 | 2 | HP:0000756 | |
| HumanPheno | Humoral immunodeficiency | 6.92e-05 | 3 | 25 | 2 | HP:0005363 | |
| HumanPheno | Prominent nasal septum | 6.92e-05 | 3 | 25 | 2 | HP:0005322 | |
| HumanPheno | Radial deviation of thumb terminal phalanx | 6.92e-05 | 3 | 25 | 2 | HP:0005895 | |
| HumanPheno | Trichiasis | 1.38e-04 | 4 | 25 | 2 | HP:0001128 | |
| HumanPheno | Visceral hemangioma | 1.38e-04 | 4 | 25 | 2 | HP:0410266 | |
| HumanPheno | Talon cusp | 1.38e-04 | 4 | 25 | 2 | HP:0011087 | |
| HumanPheno | Widened distal phalanges | 1.38e-04 | 4 | 25 | 2 | HP:0006200 | |
| HumanPheno | Vascular ring | 1.38e-04 | 4 | 25 | 2 | HP:0010775 | |
| HumanPheno | Hepatic hemangioma | 1.38e-04 | 4 | 25 | 2 | HP:0031207 | |
| HumanPheno | Low hanging columella | 1.40e-04 | 56 | 25 | 4 | HP:0009765 | |
| HumanPheno | Hyperactivity | ANK3 ATRX KMT5B SLF2 NEXMIF SCAPER ANKRD17 TRIP12 CREBBP EP300 | 1.62e-04 | 558 | 25 | 10 | HP:0000752 |
| HumanPheno | Abnormality of renal physiology | AHI1 TRAF3IP1 ATRX DYNC2H1 NEXMIF SCAPER CREBBP DNASE1L3 EP300 SLX4 FAN1 | 1.93e-04 | 691 | 25 | 11 | HP:0000082 |
| HumanPheno | Abnormal renal medulla morphology | 2.08e-04 | 62 | 25 | 4 | HP:0100957 | |
| HumanPheno | Short first metatarsal | 2.29e-04 | 5 | 25 | 2 | HP:0010105 | |
| HumanPheno | Papillary cystadenoma of the epididymis | 2.29e-04 | 5 | 25 | 2 | HP:0009715 | |
| HumanPheno | Supernumerary cusp | 2.29e-04 | 5 | 25 | 2 | HP:0033777 | |
| HumanPheno | Epididymal neoplasm | 2.29e-04 | 5 | 25 | 2 | HP:0030421 | |
| HumanPheno | Perimembranous ventricular septal defect | 2.52e-04 | 26 | 25 | 3 | HP:0011682 | |
| HumanPheno | Motor stereotypy | 2.87e-04 | 280 | 25 | 7 | HP:0000733 | |
| HumanPheno | Increased body weight | 3.33e-04 | 491 | 25 | 9 | HP:0004324 | |
| HumanPheno | Large foramen magnum | 3.43e-04 | 6 | 25 | 2 | HP:0002700 | |
| HumanPheno | Slanting of the palpebral fissure | ATRX SLF2 NEXMIF PGAP1 VPS35L SCAPER ANKRD17 TRIP12 CREBBP EP300 SLX4 | 3.54e-04 | 739 | 25 | 11 | HP:0200006 |
| HumanPheno | Hypoplastic iliac wing | 4.29e-04 | 31 | 25 | 3 | HP:0002866 | |
| HumanPheno | Abnormal 5th finger morphology | 4.36e-04 | 509 | 25 | 9 | HP:0004207 | |
| HumanPheno | Deviated nasal septum | 4.78e-04 | 7 | 25 | 2 | HP:0004411 | |
| HumanPheno | Abnormal posterior cranial fossa morphology | 5.51e-04 | 221 | 25 | 6 | HP:0000932 | |
| HumanPheno | Truncal obesity | 6.10e-04 | 82 | 25 | 4 | HP:0001956 | |
| HumanPheno | Aplasia/hypoplasia of the 1st metatarsal | 6.36e-04 | 8 | 25 | 2 | HP:0010067 | |
| HumanPheno | Acetabular spurs | 6.36e-04 | 8 | 25 | 2 | HP:0010454 | |
| HumanPheno | Short phalanx of hallux | 6.36e-04 | 8 | 25 | 2 | HP:0010111 | |
| HumanPheno | Aplasia/hypoplasia of proximal toe phalanx | 6.36e-04 | 8 | 25 | 2 | HP:0010203 | |
| HumanPheno | Hematological neoplasm | 6.56e-04 | 424 | 25 | 8 | HP:0004377 | |
| HumanPheno | Obesity | 6.66e-04 | 425 | 25 | 8 | HP:0001513 | |
| HumanPheno | Abnormal renal morphology | AHI1 EVC2 TRAF3IP1 ATRX DYNC2H1 NEXMIF VPS35L SCAPER ANKRD17 CREBBP DNASE1L3 EP300 SLX4 FAN1 | 7.39e-04 | 1252 | 25 | 14 | HP:0012210 |
| HumanPheno | Short digit | ZNF141 EVC2 ATRX DYNC2H1 NEXMIF VPS35L SCAPER CREBBP EP300 SLX4 | 7.55e-04 | 672 | 25 | 10 | HP:0011927 |
| HumanPheno | Thin vermilion border | 7.55e-04 | 433 | 25 | 8 | HP:0000233 | |
| HumanPheno | Disinhibition | ANK3 ATRX KMT5B SLF2 NEXMIF PGAP1 SCAPER ANKRD17 TRIP12 CREBBP EP300 | 7.71e-04 | 807 | 25 | 11 | HP:0000734 |
| HumanPheno | Inappropriate behavior | ANK3 ATRX KMT5B SLF2 NEXMIF PGAP1 SCAPER ANKRD17 TRIP12 CREBBP EP300 | 7.71e-04 | 807 | 25 | 11 | HP:0000719 |
| HumanPheno | Abnormal response to social norms | ANK3 ATRX KMT5B SLF2 NEXMIF PGAP1 SCAPER ANKRD17 TRIP12 CREBBP EP300 | 7.71e-04 | 807 | 25 | 11 | HP:5200123 |
| HumanPheno | Social disinhibition | ANK3 ATRX KMT5B SLF2 NEXMIF PGAP1 SCAPER ANKRD17 TRIP12 CREBBP EP300 | 7.71e-04 | 807 | 25 | 11 | HP:5200029 |
| HumanPheno | Natal tooth | 7.87e-04 | 38 | 25 | 3 | HP:0000695 | |
| HumanPheno | Autistic behavior | ANK3 ATRX KMT5B SLF2 NEXMIF SCAPER ANKRD17 TRIP12 CREBBP EP300 | 8.11e-04 | 678 | 25 | 10 | HP:0000729 |
| HumanPheno | Pilomatrixoma | 8.15e-04 | 9 | 25 | 2 | HP:0030434 | |
| HumanPheno | Cervical cord compression | 8.15e-04 | 9 | 25 | 2 | HP:0002341 | |
| HumanPheno | Upslanted palpebral fissure | 8.24e-04 | 333 | 25 | 7 | HP:0000582 | |
| HumanPheno | Functional abnormality of male internal genitalia | FSIP2 SYCP2 AHI1 EVC2 ATRX KMT5B DYNC2H1 VPS35L SCAPER RP1 CFAP69 CREBBP EP300 SLX4 | 8.56e-04 | 1269 | 25 | 14 | HP:0000025 |
| HumanPheno | Abnormal skull base morphology | 8.92e-04 | 242 | 25 | 6 | HP:0002693 | |
| HumanPheno | Thin upper lip vermilion | 9.17e-04 | 339 | 25 | 7 | HP:0000219 | |
| HumanPheno | Thin lips | 9.17e-04 | 339 | 25 | 7 | HP:0000213 | |
| HumanPheno | Frontal hirsutism | 1.02e-03 | 10 | 25 | 2 | HP:0011335 | |
| HumanPheno | Abnormal antihelix morphology | 1.13e-03 | 43 | 25 | 3 | HP:0009738 | |
| HumanPheno | Abnormal columella morphology | 1.15e-03 | 97 | 25 | 4 | HP:0009929 | |
| HumanPheno | Hand polydactyly | 1.15e-03 | 254 | 25 | 6 | HP:0001161 | |
| HumanPheno | Duplication of phalanx of hand | 1.22e-03 | 257 | 25 | 6 | HP:0009997 | |
| HumanPheno | Abnormal subclavian artery morphology | 1.24e-03 | 11 | 25 | 2 | HP:0031251 | |
| HumanPheno | Abnormal male reproductive system physiology | FSIP2 SYCP2 AHI1 EVC2 ATRX KMT5B DYNC2H1 VPS35L SCAPER RP1 CFAP69 CREBBP EP300 SLX4 | 1.24e-03 | 1314 | 25 | 14 | HP:0012874 |
| HumanPheno | Duplication of hand bones | 1.25e-03 | 258 | 25 | 6 | HP:0004275 | |
| HumanPheno | Duplication of bones involving the upper extremities | 1.25e-03 | 258 | 25 | 6 | HP:0009142 | |
| HumanPheno | Postnatal growth retardation | 1.25e-03 | 258 | 25 | 6 | HP:0008897 | |
| HumanPheno | Abnormal hallux phalanx morphology | 1.38e-03 | 46 | 25 | 3 | HP:0010057 | |
| HumanPheno | Advanced eruption of teeth | 1.38e-03 | 46 | 25 | 3 | HP:0006288 | |
| HumanPheno | Hydronephrosis | 1.41e-03 | 264 | 25 | 6 | HP:0000126 | |
| HumanPheno | Abnormal lower limb bone morphology | ZNF141 AHI1 EVC2 TRAF3IP1 ATRX DYNC2H1 NEXMIF VPS35L CREBBP EP300 SLX4 | 1.42e-03 | 866 | 25 | 11 | HP:0040069 |
| HumanPheno | Abnormally increased volition | ANK3 ATRX KMT5B SLF2 NEXMIF PGAP1 SCAPER ANKRD17 TRIP12 CREBBP EP300 | 1.46e-03 | 869 | 25 | 11 | HP:5200263 |
| HumanPheno | Hypoplasia of the phalanges of the toes | 1.48e-03 | 12 | 25 | 2 | HP:0010746 | |
| HumanPheno | Restricted or repetitive behaviors or interests | 1.49e-03 | 368 | 25 | 7 | HP:0031432 | |
| HumanPheno | Abnormality of the palpebral fissures | ATRX SLF2 NEXMIF PGAP1 VPS35L SCAPER ANKRD17 TRIP12 CREBBP EP300 SLX4 | 1.63e-03 | 880 | 25 | 11 | HP:0008050 |
| HumanPheno | Hypoplastic left heart | 1.66e-03 | 49 | 25 | 3 | HP:0004383 | |
| HumanPheno | Depressed nasal bridge | 1.69e-03 | 612 | 25 | 9 | HP:0005280 | |
| HumanPheno | Flattened nasal bridge | 1.69e-03 | 612 | 25 | 9 | HP:0000425 | |
| HumanPheno | Abnormality of the incisor | 1.71e-03 | 108 | 25 | 4 | HP:0000676 | |
| HumanPheno | Perseverative thought | 1.72e-03 | 377 | 25 | 7 | HP:0030223 | |
| HumanPheno | Facial grimacing | 1.75e-03 | 13 | 25 | 2 | HP:0000273 | |
| HumanPheno | Abnormality of the first metatarsal bone | 1.75e-03 | 13 | 25 | 2 | HP:0010054 | |
| HumanPheno | Aplasia/Hypoplasia of the phalanges of the hallux | 1.75e-03 | 13 | 25 | 2 | HP:0010058 | |
| HumanPheno | Keloids | 1.75e-03 | 13 | 25 | 2 | HP:0010562 | |
| HumanPheno | Diagnostic behavioral phenotype | ANK3 ATRX KMT5B SLF2 NEXMIF SCAPER ANKRD17 TRIP12 CREBBP EP300 | 1.75e-03 | 747 | 25 | 10 | HP:0025783 |
| HumanPheno | Congenital malformation of the left heart | 1.86e-03 | 51 | 25 | 3 | HP:0045017 | |
| HumanPheno | Abnormal epiphysis morphology | 1.87e-03 | 279 | 25 | 6 | HP:0005930 | |
| HumanPheno | Abnormal palate morphology | AHI1 EVC2 ATRX SLF2 DYNC2H1 PGAP1 VPS35L SCAPER ANKRD17 TRIP12 CREBBP EP300 SLX4 | 1.89e-03 | 1202 | 25 | 13 | HP:0000174 |
| HumanPheno | Disordered formal thought process | 1.97e-03 | 386 | 25 | 7 | HP:0025769 | |
| HumanPheno | Abnormal proximal phalanx morphology of the hand | 1.97e-03 | 52 | 25 | 3 | HP:0009834 | |
| HumanPheno | Duplication of phalanx of hallux | 2.03e-03 | 14 | 25 | 2 | HP:0010066 | |
| HumanPheno | Abnormality of toe proximal phalanx | 2.03e-03 | 14 | 25 | 2 | HP:0010184 | |
| HumanPheno | Hypoplastic aortic arch | 2.03e-03 | 14 | 25 | 2 | HP:0012304 | |
| HumanPheno | Parietal foramina | 2.03e-03 | 14 | 25 | 2 | HP:0002697 | |
| HumanPheno | Absent or minimally ossified vertebral bodies | 2.03e-03 | 14 | 25 | 2 | HP:0004599 | |
| HumanPheno | Abnormal social development | ANK3 ATRX KMT5B SLF2 NEXMIF PGAP1 SCAPER ANKRD17 TRIP12 CREBBP EP300 | 2.12e-03 | 908 | 25 | 11 | HP:0025732 |
| HumanPheno | Abnormal nasal septum morphology | 2.16e-03 | 115 | 25 | 4 | HP:0000419 | |
| Domain | Nuc_rcpt_coact_CREBbp | 1.47e-05 | 2 | 72 | 2 | IPR014744 | |
| Domain | HAT_KAT11 | 1.47e-05 | 2 | 72 | 2 | PF08214 | |
| Domain | KIX | 1.47e-05 | 2 | 72 | 2 | PS50952 | |
| Domain | ZnF_TAZ | 1.47e-05 | 2 | 72 | 2 | SM00551 | |
| Domain | CBP_P300_HAT | 1.47e-05 | 2 | 72 | 2 | IPR031162 | |
| Domain | DUF902 | 1.47e-05 | 2 | 72 | 2 | PF06001 | |
| Domain | - | 1.47e-05 | 2 | 72 | 2 | 1.20.1020.10 | |
| Domain | RING_CBP-p300 | 1.47e-05 | 2 | 72 | 2 | IPR010303 | |
| Domain | - | 1.47e-05 | 2 | 72 | 2 | 1.10.1630.10 | |
| Domain | Creb_binding | 1.47e-05 | 2 | 72 | 2 | PF09030 | |
| Domain | - | 1.47e-05 | 2 | 72 | 2 | 1.10.246.20 | |
| Domain | zf-TAZ | 1.47e-05 | 2 | 72 | 2 | PF02135 | |
| Domain | ZF_TAZ | 1.47e-05 | 2 | 72 | 2 | PS50134 | |
| Domain | Histone_AcTrfase_Rtt109/CBP | 1.47e-05 | 2 | 72 | 2 | IPR013178 | |
| Domain | KAT11 | 1.47e-05 | 2 | 72 | 2 | SM01250 | |
| Domain | Znf_TAZ | 1.47e-05 | 2 | 72 | 2 | IPR000197 | |
| Domain | KIX_dom | 1.47e-05 | 2 | 72 | 2 | IPR003101 | |
| Domain | KIX | 1.47e-05 | 2 | 72 | 2 | PF02172 | |
| Domain | CBP_P300_HAT | 1.47e-05 | 2 | 72 | 2 | PS51727 | |
| Domain | PHR | 1.45e-04 | 5 | 72 | 2 | PF08005 | |
| Domain | PHR | 1.45e-04 | 5 | 72 | 2 | IPR012983 | |
| Domain | Nuc_rcpt_coact | 2.18e-04 | 6 | 72 | 2 | IPR009110 | |
| Domain | DAD_dom | 4.04e-04 | 8 | 72 | 2 | IPR014767 | |
| Domain | DAD | 4.04e-04 | 8 | 72 | 2 | PS51231 | |
| Domain | Drf_GBD | 5.18e-04 | 9 | 72 | 2 | PF06371 | |
| Domain | FH3_dom | 5.18e-04 | 9 | 72 | 2 | IPR010472 | |
| Domain | GTPase-bd | 5.18e-04 | 9 | 72 | 2 | IPR010473 | |
| Domain | Drf_FH3 | 5.18e-04 | 9 | 72 | 2 | PF06367 | |
| Domain | Drf_FH3 | 5.18e-04 | 9 | 72 | 2 | SM01139 | |
| Domain | Drf_GBD | 5.18e-04 | 9 | 72 | 2 | SM01140 | |
| Domain | Ank_3 | 6.46e-04 | 10 | 72 | 2 | PF13606 | |
| Domain | GBD/FH3_dom | 7.88e-04 | 11 | 72 | 2 | IPR014768 | |
| Domain | GBD_FH3 | 7.88e-04 | 11 | 72 | 2 | PS51232 | |
| Domain | WWE | 9.43e-04 | 12 | 72 | 2 | PS50918 | |
| Domain | WWE | 9.43e-04 | 12 | 72 | 2 | PF02825 | |
| Domain | WWE-dom | 9.43e-04 | 12 | 72 | 2 | IPR004170 | |
| Domain | FH2 | 1.49e-03 | 15 | 72 | 2 | PS51444 | |
| Domain | FH2_Formin | 1.49e-03 | 15 | 72 | 2 | IPR015425 | |
| Domain | FH2 | 1.49e-03 | 15 | 72 | 2 | PF02181 | |
| Domain | FH2 | 1.49e-03 | 15 | 72 | 2 | SM00498 | |
| Domain | ARM-type_fold | 1.95e-03 | 339 | 72 | 6 | IPR016024 | |
| Domain | ZZ | 2.15e-03 | 18 | 72 | 2 | PF00569 | |
| Domain | ZF_ZZ_2 | 2.15e-03 | 18 | 72 | 2 | PS50135 | |
| Domain | ZF_ZZ_1 | 2.15e-03 | 18 | 72 | 2 | PS01357 | |
| Domain | Znf_ZZ | 2.40e-03 | 19 | 72 | 2 | IPR000433 | |
| Domain | ZnF_ZZ | 2.40e-03 | 19 | 72 | 2 | SM00291 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 7.46e-05 | 65 | 49 | 4 | M39682 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 1.18e-04 | 5 | 49 | 2 | MM1575 | |
| Pathway | REACTOME_NFE2L2_REGULATING_INFLAMMATION_ASSOCIATED_GENES | 1.18e-04 | 5 | 49 | 2 | M48020 | |
| Pathway | REACTOME_LRR_FLII_INTERACTING_PROTEIN_1_LRRFIP1_ACTIVATES_TYPE_I_IFN_PRODUCTION | 1.18e-04 | 5 | 49 | 2 | M27228 | |
| Pathway | REACTOME_NFE2L2_REGULATING_ER_STRESS_ASSOCIATED_GENES | 1.18e-04 | 5 | 49 | 2 | M48023 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 1.21e-04 | 140 | 49 | 5 | M27550 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 1.25e-04 | 141 | 49 | 5 | MM15266 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 1.76e-04 | 6 | 49 | 2 | M22062 | |
| Pathway | WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR | 1.82e-04 | 32 | 49 | 3 | M39521 | |
| Pathway | WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA | 2.19e-04 | 34 | 49 | 3 | M39771 | |
| Pathway | WP_BARDETBIEDL_SYNDROME | 2.42e-04 | 88 | 49 | 4 | M45557 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 2.46e-04 | 7 | 49 | 2 | MM1573 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 3.27e-04 | 8 | 49 | 2 | M22058 | |
| Pathway | REACTOME_NFE2L2_REGULATING_MDR_ASSOCIATED_ENZYMES | 3.27e-04 | 8 | 49 | 2 | M48022 | |
| Pathway | REACTOME_REGULATION_OF_NFE2L2_GENE_EXPRESSION | 3.27e-04 | 8 | 49 | 2 | M48024 | |
| Pathway | REACTOME_NFE2L2_REGULATES_PENTOSE_PHOSPHATE_PATHWAY_GENES | 3.27e-04 | 8 | 49 | 2 | M46443 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR3_IRF3_SIGNALING_PATHWAY | 4.20e-04 | 9 | 49 | 2 | M47451 | |
| Pathway | WP_CILIOPATHIES | 4.30e-04 | 184 | 49 | 5 | M39880 | |
| Pathway | REACTOME_REGULATION_OF_FOXO_TRANSCRIPTIONAL_ACTIVITY_BY_ACETYLATION | 5.23e-04 | 10 | 49 | 2 | M27945 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 5.75e-04 | 47 | 49 | 3 | M7946 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 6.38e-04 | 11 | 49 | 2 | MM1521 | |
| Pathway | REACTOME_NFE2L2_REGULATING_TUMORIGENIC_GENES | 6.38e-04 | 11 | 49 | 2 | M48021 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR | 6.38e-04 | 11 | 49 | 2 | M26924 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 7.64e-04 | 12 | 49 | 2 | M7968 | |
| Pathway | REACTOME_ACTIVATION_OF_THE_TFAP2_AP_2_FAMILY_OF_TRANSCRIPTION_FACTORS | 7.64e-04 | 12 | 49 | 2 | M27765 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 1.05e-03 | 14 | 49 | 2 | M27808 | |
| Pathway | WP_15Q11Q13_COPY_NUMBER_VARIATION | 1.12e-03 | 59 | 49 | 3 | M48104 | |
| Pathway | BIOCARTA_RELA_PATHWAY | 1.21e-03 | 15 | 49 | 2 | MM1339 | |
| Pathway | BIOCARTA_RELA_PATHWAY | 1.21e-03 | 15 | 49 | 2 | M10183 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 1.21e-03 | 15 | 49 | 2 | MM1439 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LESION_BYPASS_BY_TLS_AND_DSB_FORMATION | 1.21e-03 | 15 | 49 | 2 | M47854 | |
| Pathway | REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY | 1.21e-03 | 15 | 49 | 2 | M953 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 1.38e-03 | 16 | 49 | 2 | M1296 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 1.38e-03 | 16 | 49 | 2 | MM1420 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 1.38e-03 | 16 | 49 | 2 | M8516 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS | 1.38e-03 | 16 | 49 | 2 | M27121 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_DEATH_GENES | 1.38e-03 | 16 | 49 | 2 | M27940 | |
| Pathway | REACTOME_CYTOSOLIC_SENSORS_OF_PATHOGEN_ASSOCIATED_DNA | 1.42e-03 | 64 | 49 | 3 | M27046 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 1.56e-03 | 17 | 49 | 2 | MM1509 | |
| Pathway | REACTOME_ZYGOTIC_GENOME_ACTIVATION_ZGA | 1.56e-03 | 17 | 49 | 2 | M48025 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 1.75e-03 | 18 | 49 | 2 | MM14775 | |
| Pathway | REACTOME_RORA_ACTIVATES_GENE_EXPRESSION | 1.75e-03 | 18 | 49 | 2 | M26942 | |
| Pathway | REACTOME_CIRCADIAN_CLOCK | 1.83e-03 | 70 | 49 | 3 | M938 | |
| Pathway | REACTOME_RHOC_GTPASE_CYCLE | 1.83e-03 | 70 | 49 | 3 | MM15597 | |
| Pathway | WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME | 1.91e-03 | 71 | 49 | 3 | M39860 | |
| Pathway | REACTOME_RHO_GTPASE_EFFECTORS | 1.92e-03 | 257 | 49 | 5 | MM14755 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 1.95e-03 | 19 | 49 | 2 | M18933 | |
| Pathway | REACTOME_NFE2L2_REGULATING_ANTI_OXIDANT_DETOXIFICATION_ENZYMES | 1.95e-03 | 19 | 49 | 2 | M46442 | |
| Pathway | REACTOME_RHOC_GTPASE_CYCLE | 2.15e-03 | 74 | 49 | 3 | M41807 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 2.15e-03 | 74 | 49 | 3 | M616 | |
| Pathway | REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 2.16e-03 | 20 | 49 | 2 | M27881 | |
| Pathway | WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX | 2.38e-03 | 21 | 49 | 2 | M39593 | |
| Pathway | REACTOME_CD209_DC_SIGN_SIGNALING | 2.38e-03 | 21 | 49 | 2 | M27485 | |
| Pathway | BIOCARTA_NTHI_PATHWAY | 2.62e-03 | 22 | 49 | 2 | MM1443 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 2.62e-03 | 22 | 49 | 2 | MM1370 | |
| Pathway | WP_15Q133_COPY_NUMBER_VARIATION_SYNDROME | 2.86e-03 | 23 | 49 | 2 | M39883 | |
| Pathway | BIOCARTA_NTHI_PATHWAY | 2.86e-03 | 23 | 49 | 2 | M2821 | |
| Pathway | PID_REG_GR_PATHWAY | 2.88e-03 | 82 | 49 | 3 | M115 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 3.11e-03 | 24 | 49 | 2 | M13404 | |
| Pathway | REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 3.37e-03 | 25 | 49 | 2 | M27880 | |
| Pathway | REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE | 3.59e-03 | 297 | 49 | 5 | M27050 | |
| Pathway | BIOCARTA_CARM_ER_PATHWAY | 3.65e-03 | 26 | 49 | 2 | M2499 | |
| Pathway | PID_HDAC_CLASSIII_PATHWAY | 3.65e-03 | 26 | 49 | 2 | M32 | |
| Pathway | REACTOME_ATTENUATION_PHASE | 4.22e-03 | 28 | 49 | 2 | M27254 | |
| Pathway | PID_RETINOIC_ACID_PATHWAY | 4.84e-03 | 30 | 49 | 2 | M207 | |
| Pathway | REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION | 4.84e-03 | 30 | 49 | 2 | M936 | |
| Pathway | REACTOME_AMPLIFICATION_OF_SIGNAL_FROM_THE_KINETOCHORES | 5.04e-03 | 100 | 49 | 3 | MM14561 | |
| Pathway | REACTOME_RHO_GTPASE_EFFECTORS | 5.11e-03 | 323 | 49 | 5 | M27080 | |
| Pathway | REACTOME_CILIUM_ASSEMBLY | 5.15e-03 | 201 | 49 | 4 | M27472 | |
| Pubmed | UNC13B JCAD ANK3 TRAF3IP1 ATRX MYCBP2 SLF2 VPS35L FMNL2 TRIP12 CREBBP PREX1 EP300 SLX4 PCM1 FAN1 | 2.18e-08 | 1285 | 78 | 16 | 35914814 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | NELFE ATRX CENPC SLF2 ATAD5 PA2G4 RBM4 AHCTF1 STAU2 SGO2 QSER1 TRIP12 SLX4 PCM1 | 2.49e-08 | 954 | 78 | 14 | 36373674 |
| Pubmed | AHI1 ANK3 KIN ATRX PA2G4 AHCTF1 PGAP1 VPS35L DIAPH1 ANKRD17 P2RY14 QSER1 TRIP12 SLX4 | 1.20e-07 | 1084 | 78 | 14 | 11544199 | |
| Pubmed | 8.31e-07 | 591 | 78 | 10 | 15231748 | ||
| Pubmed | HIV-1 chromatin, transcription, and the regulatory protein Tat. | 9.03e-07 | 9 | 78 | 3 | 24158816 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | PITPNM2 ANK3 ATRX MYCBP2 ATXN7L1 RBM4 VPS35L ANKRD17 QSER1 CFAP69 CREBBP UBE2E3 EP300 PCM1 PPP4R4 | 9.55e-07 | 1489 | 78 | 15 | 28611215 |
| Pubmed | KMT5B CCNB3 ATAD5 ATXN7L1 AHCTF1 SCAPER DIAPH1 SAP30L ANKRD17 FMNL2 CREBBP EP300 PCM1 | 1.14e-06 | 1116 | 78 | 13 | 31753913 | |
| Pubmed | CENPC MYCBP2 ATAD5 DIAPH1 SGO2 TRIP12 CREBBP EP300 EDRF1 PCM1 | 1.82e-06 | 645 | 78 | 10 | 25281560 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | NELFE FSIP2 JCAD MYCBP2 SLF2 KCTD8 ANKRD17 TRIP12 EDRF1 PCM1 PPP4R4 | 3.45e-06 | 861 | 78 | 11 | 36931259 |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 27881875 | ||
| Pubmed | Molecular characterization of the histone acetyltransferase CREBBP/EP300 genes in myeloid neoplasia. | 4.97e-06 | 2 | 78 | 2 | 34845315 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 19729597 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 15860545 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 29460469 | ||
| Pubmed | Expression of p300 and CBP is associated with poor prognosis in small cell lung cancer. | 4.97e-06 | 2 | 78 | 2 | 24551300 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 33911074 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 9018065 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 24648406 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 30135524 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 39287984 | ||
| Pubmed | Distribution of co-activators CBP and p300 during mouse oocyte and embryo development. | 4.97e-06 | 2 | 78 | 2 | 16596650 | |
| Pubmed | The p300 and CBP Transcriptional Coactivators Are Required for β-Cell and α-Cell Proliferation. | 4.97e-06 | 2 | 78 | 2 | 29217654 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 20717166 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 10049825 | ||
| Pubmed | CBP/p300 acetyltransferase activity in hematologic malignancies. | 4.97e-06 | 2 | 78 | 2 | 27380996 | |
| Pubmed | CREBBP and p300 lysine acetyl transferases in the DNA damage response. | 4.97e-06 | 2 | 78 | 2 | 29170789 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 25893291 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 11559821 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 21555743 | ||
| Pubmed | CBP/p300 induction is required for retinoic acid sensitivity in human mammary cells. | 4.97e-06 | 2 | 78 | 2 | 12646247 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 32576962 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 19822209 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 24522976 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 11867645 | ||
| Pubmed | CBP is required for environmental enrichment-induced neurogenesis and cognitive enhancement. | 4.97e-06 | 2 | 78 | 2 | 21847097 | |
| Pubmed | Expression of the nuclear coactivators CBP and p300 in developing craniofacial tissue. | 4.97e-06 | 2 | 78 | 2 | 11963968 | |
| Pubmed | p300 or CBP is required for insulin-stimulated glucose uptake in skeletal muscle and adipocytes. | 4.97e-06 | 2 | 78 | 2 | 34813504 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 9528808 | ||
| Pubmed | Analysis of genetic stability at the EP300 and CREBBP loci in a panel of cancer cell lines. | 4.97e-06 | 2 | 78 | 2 | 12696060 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 20301699 | ||
| Pubmed | CBP Is Required for Establishing Adaptive Gene Programs in the Adult Mouse Brain. | 4.97e-06 | 2 | 78 | 2 | 36109165 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 24639469 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 37816914 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 12242694 | ||
| Pubmed | Binding of p300/CBP co-activators by polyoma large T antigen. | 4.97e-06 | 2 | 78 | 2 | 11438528 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 10918613 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 31182547 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 35502657 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 30635043 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 31898871 | ||
| Pubmed | Phenotype and genotype in 52 patients with Rubinstein-Taybi syndrome caused by EP300 mutations. | 4.97e-06 | 2 | 78 | 2 | 27648933 | |
| Pubmed | Germline or inducible knockout of p300 or CBP in skeletal muscle does not alter insulin sensitivity. | 4.97e-06 | 2 | 78 | 2 | 30888860 | |
| Pubmed | Exploitation of EP300 and CREBBP Lysine Acetyltransferases by Cancer. | 4.97e-06 | 2 | 78 | 2 | 27881443 | |
| Pubmed | Formins regulate actin filament flexibility through long range allosteric interactions. | 4.97e-06 | 2 | 78 | 2 | 16490788 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 19272189 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 10610021 | ||
| Pubmed | Emerging roles of p300/CBP in autophagy and autophagy-related human disorders. | 4.97e-06 | 2 | 78 | 2 | 37314181 | |
| Pubmed | Distinct roles for CREB-binding protein and p300 in hematopoietic stem cell self-renewal. | 4.97e-06 | 2 | 78 | 2 | 12397173 | |
| Pubmed | CBP/p300 TAZ1 domain forms a structured scaffold for ligand binding. | 4.97e-06 | 2 | 78 | 2 | 15641773 | |
| Pubmed | Differential contribution of p300 and CBP to regulatory element acetylation in mESCs. | 4.97e-06 | 2 | 78 | 2 | 32690000 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 9733868 | ||
| Pubmed | Formin and capping protein together embrace the actin filament in a ménage à trois. | 4.97e-06 | 2 | 78 | 2 | 26564775 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 30953353 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 21803292 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 9811832 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 24089570 | ||
| Pubmed | Rubinstein-Taybi syndrome in Chinese population with four novel mutations. | 4.97e-06 | 2 | 78 | 2 | 33063428 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 34506759 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 22177454 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 15706485 | ||
| Pubmed | AR coactivators, CBP/p300, are critical mediators of DNA repair in prostate cancer. | 4.97e-06 | 2 | 78 | 2 | 39266679 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 22303793 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 34732714 | ||
| Pubmed | Targeting histone acetylation dynamics and oncogenic transcription by catalytic P300/CBP inhibition. | 4.97e-06 | 2 | 78 | 2 | 34019788 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | C18orf21 KIN MYCBP2 ATAD5 PA2G4 RBM4 STAU2 SCAPER SGO2 TRIP12 | 7.63e-06 | 759 | 78 | 10 | 35915203 |
| Pubmed | 8.64e-06 | 18 | 78 | 3 | 33323119 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 8.97e-06 | 608 | 78 | 9 | 36089195 | |
| Pubmed | 1.11e-05 | 222 | 78 | 6 | 37071664 | ||
| Pubmed | 1.32e-05 | 638 | 78 | 9 | 31182584 | ||
| Pubmed | Dendrite development regulated by CREST, a calcium-regulated transcriptional activator. | 1.49e-05 | 3 | 78 | 2 | 14716005 | |
| Pubmed | 1.49e-05 | 3 | 78 | 2 | 18070920 | ||
| Pubmed | The acetylation of transcription factor HBP1 by p300/CBP enhances p16INK4A expression. | 1.49e-05 | 3 | 78 | 2 | 21967847 | |
| Pubmed | CBP and p300 are essential for renin cell identity and morphological integrity of the kidney. | 1.49e-05 | 3 | 78 | 2 | 19252086 | |
| Pubmed | 1.49e-05 | 3 | 78 | 2 | 27903646 | ||
| Pubmed | 1.49e-05 | 3 | 78 | 2 | 12748286 | ||
| Pubmed | 1.49e-05 | 3 | 78 | 2 | 10075656 | ||
| Pubmed | 1.49e-05 | 3 | 78 | 2 | 24340053 | ||
| Pubmed | 1.49e-05 | 3 | 78 | 2 | 19273602 | ||
| Pubmed | 1.49e-05 | 3 | 78 | 2 | 15649887 | ||
| Pubmed | Expression patterns of histone acetyltransferases p300 and CBP during murine tooth development. | 1.49e-05 | 3 | 78 | 2 | 22179676 | |
| Pubmed | 1.49e-05 | 3 | 78 | 2 | 17410209 | ||
| Pubmed | DUX4 recruits p300/CBP through its C-terminus and induces global H3K27 acetylation changes. | 1.49e-05 | 3 | 78 | 2 | 26951377 | |
| Pubmed | CBP/p300 and SIRT1 are involved in transcriptional regulation of S-phase specific histone genes. | 1.49e-05 | 3 | 78 | 2 | 21789216 | |
| Pubmed | Mastermind mediates chromatin-specific transcription and turnover of the Notch enhancer complex. | 1.49e-05 | 3 | 78 | 2 | 12050117 | |
| Pubmed | Two transactivation mechanisms cooperate for the bulk of HIF-1-responsive gene expression. | 1.49e-05 | 3 | 78 | 2 | 16237459 | |
| Pubmed | A transcription-factor-binding surface of coactivator p300 is required for haematopoiesis. | 1.49e-05 | 3 | 78 | 2 | 12384703 | |
| Pubmed | 1.49e-05 | 3 | 78 | 2 | 10350644 | ||
| Pubmed | 1.49e-05 | 3 | 78 | 2 | 29145650 | ||
| Pubmed | 1.49e-05 | 3 | 78 | 2 | 7870179 | ||
| Pubmed | 1.49e-05 | 3 | 78 | 2 | 19041714 | ||
| Interaction | H2BC21 interactions | NELFE ZNF280D ATRX ATAD5 ATXN7L1 AHCTF1 SGO2 QSER1 FMNL2 TRIP12 CREBBP DNASE1L3 EP300 | 2.13e-06 | 696 | 77 | 13 | int:H2BC21 |
| Cytoband | 8q21.11 | 1.05e-03 | 28 | 78 | 2 | 8q21.11 | |
| Cytoband | 2q32.1 | 1.20e-03 | 30 | 78 | 2 | 2q32.1 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 6.04e-04 | 17 | 39 | 2 | 486 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 6.79e-04 | 18 | 39 | 2 | 91 | |
| GeneFamily | Ankyrin repeat domain containing | 1.78e-03 | 242 | 39 | 4 | 403 | |
| GeneFamily | X-linked mental retardation|Angiotensin receptors | 5.83e-03 | 53 | 39 | 2 | 103 | |
| Coexpression | MURARO_PANCREAS_DELTA_CELL | 9.80e-06 | 250 | 78 | 7 | M39170 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 2.46e-07 | 186 | 73 | 8 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | AHI1 TRAF3IP1 ATRX DYNC2H1 ATAD5 MTRES1 DTX4 PGAP1 GKAP1 PAPPA CFAP69 FMNL2 SLX4 PCM1 | 7.66e-07 | 831 | 73 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | AHI1 C18orf21 ANK3 ZNF280D KIN ATRX CENPC SLF2 ATAD5 MTRES1 AHCTF1 SAP30L SGO2 QSER1 UBE2E3 PCM1 | 3.75e-06 | 1241 | 73 | 16 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | ZNF280D KIN TRAF3IP1 ATRX MYCBP2 SLF2 ATAD5 ANKRD17 QSER1 PCM1 | 2.23e-05 | 564 | 73 | 10 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | UNC13B AHI1 ZNF280D TRAF3IP1 ATRX DYNC2H1 ATAD5 DTX4 PGAP1 GKAP1 PAPPA CFAP69 PCM1 | 2.88e-05 | 989 | 73 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500 | AHI1 C18orf21 ANK3 ZNF280D KIN ATRX CENPC SLF2 ATAD5 MTRES1 AHCTF1 SAP30L SGO2 QSER1 UBE2E3 PCM1 | 3.07e-05 | 1468 | 73 | 16 | facebase_RNAseq_e10.5_MandArch_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500 | 4.66e-05 | 492 | 73 | 9 | Facebase_RNAseq_e10.5_Mandibular Arch_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 5.20e-05 | 192 | 73 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | ZNF280D KIN TRAF3IP1 ATRX SLF2 DYNC2H1 ATAD5 QSER1 PCM1 RNF157 | 5.61e-05 | 629 | 73 | 10 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | UNC13B AHI1 ZNF280D ATRX CENPC ATAD5 NEXMIF DTX4 PGAP1 SGO2 PAPPA QSER1 PCM1 | 5.88e-05 | 1060 | 73 | 13 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | AHI1 C18orf21 ZNF280D KIN TRAF3IP1 ATRX CENPC ATAD5 AHCTF1 SGO2 PAPPA QSER1 FMNL2 PCM1 | 8.33e-05 | 1257 | 73 | 14 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | 1.16e-04 | 432 | 73 | 8 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 1.18e-04 | 139 | 73 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500_K4 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.48e-04 | 146 | 73 | 5 | gudmap_developingKidney_e15.5_Cap mesenchyme_1000_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | 1.97e-04 | 595 | 73 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | UNC13B AHI1 ZNF280D KIN ATRX CENPC DYNC2H1 ATAD5 DTX4 PGAP1 GKAP1 SAMSN1 FMNL2 PCM1 | 2.06e-04 | 1370 | 73 | 14 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.74e-04 | 91 | 73 | 4 | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k3_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | 3.06e-04 | 498 | 73 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | AHI1 C18orf21 ZNF280D KIN TRAF3IP1 ATRX CENPC ATAD5 AHCTF1 SGO2 PAPPA QSER1 FMNL2 PCM1 | 3.93e-04 | 1459 | 73 | 14 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000 | AHI1 ZNF280D TRAF3IP1 SLF2 NEXMIF SAP30L SGO2 QSER1 CREBBP PCM1 RNF157 | 4.86e-04 | 978 | 73 | 11 | Facebase_RNAseq_e10.5_Mandibular Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 5.62e-04 | 298 | 73 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4 | |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_k-means-cluster#2_top-relative-expression-ranked_1000 | 6.66e-04 | 115 | 73 | 4 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_k2_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#4 | 6.74e-04 | 203 | 73 | 5 | Facebase_RNAseq_e9.5_Mandibular Arch_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 7.03e-04 | 311 | 73 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_1000 | 7.15e-04 | 312 | 73 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k2 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.15e-08 | 197 | 77 | 7 | 91637bdeab85024b5a02d1066f76cb803a2d6420 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.15e-08 | 197 | 77 | 7 | 22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.15e-08 | 197 | 77 | 7 | 3bbf068d2ad8196fbc85d3f311a7c54c9aece856 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.15e-08 | 197 | 77 | 7 | 87db09f341e2b20eb6e1c3e917cb5c960387b3e9 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.89e-07 | 169 | 77 | 6 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.07e-07 | 180 | 77 | 6 | 1f1af4474f3f0ac3c0d6b1a6c875c354d36d8eec | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.54e-07 | 182 | 77 | 6 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.03e-07 | 184 | 77 | 6 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.06e-06 | 193 | 77 | 6 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | moderate-Epithelial-FOXN4+|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.09e-06 | 194 | 77 | 6 | 5dffa578149104dda33774361e9e77b227b5f1ce | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.09e-06 | 194 | 77 | 6 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4-Tnaive/CM_CD4|Lung / Manually curated celltypes from each tissue | 9.12e-06 | 162 | 77 | 5 | 91cc14aec8d580cf97a1929bc1acb00fcbcdb57a | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.12e-05 | 169 | 77 | 5 | 8bca402e144819cb9a8d431d6bf9429be2fff6d6 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.12e-05 | 169 | 77 | 5 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | BAL-Control-cDC_11|Control / Compartment, Disease Groups and Clusters | 1.32e-05 | 175 | 77 | 5 | daf014e15a354956e9149c83fd89d0af0d07eb00 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.52e-05 | 180 | 77 | 5 | 0c146e80d55d18b6988dd21b1da635801bd3140c | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.52e-05 | 180 | 77 | 5 | e9af22beae2f3c7fe213b4e19df84abfd2453433 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.52e-05 | 180 | 77 | 5 | 11455ba704ac73f69b474845136cfecec6a88349 | |
| ToppCell | 15-Trachea-Epithelial-Multiciliated_precursor|Trachea / Age, Tissue, Lineage and Cell class | 1.73e-05 | 185 | 77 | 5 | 9a8b8360d99375b726ca8e3c9a3f9b08919892d7 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.73e-05 | 185 | 77 | 5 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | Ciliated_cells-B-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.73e-05 | 185 | 77 | 5 | f012c243343e1d1956db19b34d062e9b13de2b2a | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-05 | 185 | 77 | 5 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.78e-05 | 186 | 77 | 5 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Neuronal-Neuron|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 1.92e-05 | 189 | 77 | 5 | 3717d1148e26ac78a26aea0ca1dbfbb9d3668877 | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.02e-05 | 191 | 77 | 5 | acd844b477a069b2dcf07b2998e1b5c87dc0eb94 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.02e-05 | 191 | 77 | 5 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | IPF-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 2.07e-05 | 192 | 77 | 5 | d903bbd6c18e29e2c4cdedeb3fea1fd5ad7baa11 | |
| ToppCell | IPF-Epithelial-Ciliated|IPF / Disease state, Lineage and Cell class | 2.07e-05 | 192 | 77 | 5 | 354adc1354bf596fbc60dd45c0169688e6f45165 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.12e-05 | 193 | 77 | 5 | e1b76102f812c433195d1e8811fdd3293a7bc22e | |
| ToppCell | Control-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 2.12e-05 | 193 | 77 | 5 | 0e37d454f3735edd936ee9a5f5f516ac3aad400e | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 2.12e-05 | 193 | 77 | 5 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.17e-05 | 194 | 77 | 5 | 1ae8a10e508e672e6677f0e3c986ac30d05adeb3 | |
| ToppCell | Control-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 2.17e-05 | 194 | 77 | 5 | 958e648138676d46698090b4046cb484083ae449 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 2.23e-05 | 195 | 77 | 5 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.23e-05 | 195 | 77 | 5 | d211a836cf711fdb91b10d512f09d462be937cc5 | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 2.23e-05 | 195 | 77 | 5 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.23e-05 | 195 | 77 | 5 | 79dc031258579ea328181dda33710dd897f1064a | |
| ToppCell | NS-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.23e-05 | 195 | 77 | 5 | 34e37cff4849696ca4ba5dd8fd2cf98fed8bc912 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 2.23e-05 | 195 | 77 | 5 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.23e-05 | 195 | 77 | 5 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.23e-05 | 195 | 77 | 5 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | moderate-Epithelial-Ciliated|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.23e-05 | 195 | 77 | 5 | e80f5cdf0b18066b3e6c2f5452e58f101c67932c | |
| ToppCell | BL-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.23e-05 | 195 | 77 | 5 | 07a6bcef6af93ed87df455dee624037cb75e011a | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.23e-05 | 195 | 77 | 5 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | critical-Epithelial-Ciliated|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.28e-05 | 196 | 77 | 5 | 27b855c6e1ae44f16db998cf0e81bd686b9cee7e | |
| ToppCell | NS-control-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.28e-05 | 196 | 77 | 5 | d46ab80554dd3c1cc81e1938ea2acfd5e85c6d2a | |
| ToppCell | IPF-Epithelial|IPF / Disease state, Lineage and Cell class | 2.28e-05 | 196 | 77 | 5 | 87d9881cfec461a5d89b688a83749b618c519485 | |
| ToppCell | (05)_Ciliated|World / shred by cell type and Timepoint | 2.34e-05 | 197 | 77 | 5 | fee3cd16af8eea697cd64e8f64af505aaa2ac4b0 | |
| ToppCell | PSB-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.34e-05 | 197 | 77 | 5 | 6865f4831eb23794fb88a8649d48d497bbae3f44 | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.34e-05 | 197 | 77 | 5 | 71fea4aa6ce96c7693fa94792d08770622873850 | |
| ToppCell | control-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.34e-05 | 197 | 77 | 5 | e453d085182364ca347cbcc9dc995c62c3353016 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 2.34e-05 | 197 | 77 | 5 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | control-Epithelial-Ciliated|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.34e-05 | 197 | 77 | 5 | d4e963c1f82996371bf3d63578ee9fce8e00c5a8 | |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.40e-05 | 198 | 77 | 5 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.40e-05 | 198 | 77 | 5 | d0ecace1fad24ce50b0935036fabb07e6c9e372d | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Ciliated|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 2.52e-05 | 200 | 77 | 5 | 6a2ccc71a0cbe04a542c379b28b5006de53981c3 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 2.52e-05 | 200 | 77 | 5 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.52e-05 | 200 | 77 | 5 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuroepithelial|5w / Sample Type, Dataset, Time_group, and Cell type. | 2.52e-05 | 200 | 77 | 5 | 69707f9576d326a06faac49701ef5cd632e760f6 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuroepithelial-Proteoglycan-expressing_cell|5w / Sample Type, Dataset, Time_group, and Cell type. | 2.52e-05 | 200 | 77 | 5 | f94381d0a3b5b81cdbb13b75fc0e4910cbd70382 | |
| ToppCell | 356C-Myeloid-Macrophage-SPP1+_Macrophage_4|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 3.71e-05 | 108 | 77 | 4 | ee924deacd14ea404fda80ed633960143fd474c0 | |
| ToppCell | facs-Trachea-3m-Hematologic-myeloid-granulocyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.17e-04 | 145 | 77 | 4 | e381fd90fdaf2ff8c0d2584b6e0a4506418c9593 | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells-Ciliated|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.47e-04 | 154 | 77 | 4 | 9ca71d440c4f87781e6525b8141e7d8d470b6a8e | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.47e-04 | 154 | 77 | 4 | 58072ce422d09f2de602580325eaac6c4ec6c136 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D122|Adult / Lineage, Cell type, age group and donor | 1.58e-04 | 157 | 77 | 4 | 31d1bd9138c60e8485664ec4144f987226e3eef9 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.58e-04 | 157 | 77 | 4 | 2c5295043611bac7dfa4aef2146681bce4a33a8f | |
| ToppCell | 390C-Myeloid-Macrophage-SPP1+_Macrophage_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.74e-04 | 161 | 77 | 4 | 2fe77af3b41e6eacb707a64feea18f9991618173 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.74e-04 | 161 | 77 | 4 | 5fba13f0aa5002f7eefe219e2c6a07e163f1a50d | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-04 | 162 | 77 | 4 | 93bd29c52846c3156b8b0d2e39c552373efdfe93 | |
| ToppCell | Ciliated_cells-B-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 1.87e-04 | 164 | 77 | 4 | fd30c55d0d75ef8b9396435d836187168095152b | |
| ToppCell | droplet-Spleen-nan-3m-Myeloid-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-04 | 166 | 77 | 4 | c1f18de4a1a2b6cdc703e6d29d136e1134fcbdf3 | |
| ToppCell | 356C-Myeloid-Macrophage-SPP1+_Macrophage_4|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.96e-04 | 166 | 77 | 4 | 8d5d09f25e8903d481c2097fed435e69d42ccdb5 | |
| ToppCell | droplet-Spleen-nan-3m-Myeloid|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-04 | 166 | 77 | 4 | 94c30d6ca179d0cb02a5ed0093c5a2871e17ae50 | |
| ToppCell | lung-Ciliated_Epithelia|lung / shred on tissue and cell subclass | 2.01e-04 | 167 | 77 | 4 | 26cf1cfa58ee74794449a87eb19cd896e1ec8892 | |
| ToppCell | Bronchial_Biopsy-Immune-T_and_NK|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.05e-04 | 168 | 77 | 4 | 435b2f238fbb3f50427e8cdecf2220615015153c | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_DC-DC-DC1|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.10e-04 | 169 | 77 | 4 | 488ba50631a64cb9e0d69219491c66ac824c9e7d | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_type_2|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.10e-04 | 169 | 77 | 4 | 9c9bb1b32fc6e22359424a262178906c3954415d | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.15e-04 | 170 | 77 | 4 | a2c738e441ced90eeeb1fcc6ca3269b918aaa298 | |
| ToppCell | 356C-Myeloid-Dendritic-cDC_proliferating_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.20e-04 | 171 | 77 | 4 | b113fbebb89056af0b9c775d2fb6552206a80467 | |
| ToppCell | Bronchial_Biopsy-Immune-Mast_cells|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.25e-04 | 172 | 77 | 4 | c477008444d2d71071177807870d7455e90c2fad | |
| ToppCell | Ciliated_cells-B-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 2.25e-04 | 172 | 77 | 4 | 187ae91148d293537afc77e10da2b64302322224 | |
| ToppCell | droplet-Lung-21m-Epithelial-airway_epithelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.30e-04 | 173 | 77 | 4 | a809be2630d2b91b53b82b5e2bb99e05524597c1 | |
| ToppCell | 356C-Myeloid-Macrophage-SPP1+_Macrophage_4|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.35e-04 | 174 | 77 | 4 | 75b3a852140fb726025c3c987143d67944afde2d | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-proliferating_dendritic|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.40e-04 | 175 | 77 | 4 | a6913f992a1ea20b43e5adeca3ede3a6fda820ad | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.40e-04 | 175 | 77 | 4 | 3e56695a9db97cb1d3503425c48eb79bbf99213e | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.45e-04 | 176 | 77 | 4 | dee780cfa85234a7cd7bf440b66b84cec959893e | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.45e-04 | 176 | 77 | 4 | 5e46a09a36b9645b1b1fcb0b64bd0898561af3a9 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.50e-04 | 177 | 77 | 4 | 14fb8d182775dfd0e49aa7e4e12543a85b3b8bd6 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.56e-04 | 178 | 77 | 4 | 375156ba1c7b8592bf733c75f24968161f7cfa09 | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.61e-04 | 179 | 77 | 4 | b44e2d53b82c3c141bfc6539054b19708200a0d9 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.61e-04 | 179 | 77 | 4 | d3438fed0d85d5ed5afa8ff820c45143d77b6c0d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.67e-04 | 180 | 77 | 4 | 023ec0b080c8a5cd0f36e83c6b17d4be3c01edb5 | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-04 | 181 | 77 | 4 | 4df7972f88117108698efd06b124b232f8588981 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-Myeloid-cDC1|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.73e-04 | 181 | 77 | 4 | 84ca8c9c036478a6d3a2071919d09065455d417c | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.73e-04 | 181 | 77 | 4 | aa233b652921848af2257cc3687a7a09c3acfb67 | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-04 | 181 | 77 | 4 | cbb530566893281289026bfd93adf721decd4ca3 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-04 | 182 | 77 | 4 | e78ba2c5cae480c16a596ce7c3bf2d480becacf4 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-04 | 182 | 77 | 4 | 1710eab3037a87609d21838be2d2d29c3bc36651 | |
| ToppCell | Ciliated_cells-B-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 2.78e-04 | 182 | 77 | 4 | e93968f800bfeb258e4e834fc8bf92d1cb72cd73 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.84e-04 | 183 | 77 | 4 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| Drug | Fenbufen [36330-85-5]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 4.03e-06 | 195 | 76 | 7 | 2308_DN | |
| Drug | Gabexate mesilate [56974-61-9]; Down 200; 9.6uM; PC3; HT_HG-U133A | 4.03e-06 | 195 | 76 | 7 | 4220_DN | |
| Drug | Perhexiline maleate [6724-53-4]; Down 200; 10.2uM; PC3; HT_HG-U133A | 4.17e-06 | 196 | 76 | 7 | 5081_DN | |
| Drug | Furazolidone [67-45-8]; Down 200; 17.8uM; HL60; HT_HG-U133A | 4.31e-06 | 197 | 76 | 7 | 3019_DN | |
| Drug | Clorgyline | 2.10e-05 | 168 | 76 | 6 | ctd:D003010 | |
| Drug | carbamazepine; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA | 4.20e-05 | 190 | 76 | 6 | 952_UP | |
| Drug | Flumequine [42835-25-6]; Down 200; 15.4uM; PC3; HT_HG-U133A | 4.72e-05 | 194 | 76 | 6 | 5104_DN | |
| Drug | Erythromycin [114-07-8]; Down 200; 5.4uM; MCF7; HT_HG-U133A | 4.86e-05 | 195 | 76 | 6 | 5329_DN | |
| Drug | Cyanocobalamin [68-19-9]; Down 200; 3uM; HL60; HT_HG-U133A | 5.00e-05 | 196 | 76 | 6 | 1315_DN | |
| Drug | Iproniazide phosphate [305-33-9]; Up 200; 14.4uM; PC3; HT_HG-U133A | 5.29e-05 | 198 | 76 | 6 | 2125_UP | |
| Drug | Danazol [17230-88-5]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 5.29e-05 | 198 | 76 | 6 | 1538_DN | |
| Drug | Ondansetron Hydrochloride [103639-04-9]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 5.59e-05 | 200 | 76 | 6 | 6270_DN | |
| Disease | Menke-Hennekam syndrome | 6.55e-06 | 2 | 76 | 2 | cv:C5681632 | |
| Disease | Rubinstein-Taybi syndrome (implicated_via_orthology) | 6.55e-06 | 2 | 76 | 2 | DOID:1933 (implicated_via_orthology) | |
| Disease | Rubinstein-Taybi syndrome | 6.55e-06 | 2 | 76 | 2 | cv:C0035934 | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 6.55e-06 | 2 | 76 | 2 | C4551859 | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 6.55e-06 | 2 | 76 | 2 | 180849 | |
| Disease | Rubinstein-Taybi syndrome due to CREBBP mutations | 6.55e-06 | 2 | 76 | 2 | cv:C4551859 | |
| Disease | Rubinstein-Taybi syndrome (is_implicated_in) | 6.55e-06 | 2 | 76 | 2 | DOID:1933 (is_implicated_in) | |
| Disease | Rubinstein-Taybi Syndrome | 6.55e-06 | 2 | 76 | 2 | C0035934 | |
| Disease | Polydactyly | 1.33e-05 | 117 | 76 | 5 | C0152427 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 4.67e-05 | 152 | 76 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Adenoid Cystic Carcinoma | 1.32e-04 | 100 | 76 | 4 | C0010606 | |
| Disease | ficolin-3 measurement | 4.25e-04 | 12 | 76 | 2 | EFO_0020392 | |
| Disease | Majewski Syndrome | 5.84e-04 | 14 | 76 | 2 | C0024507 | |
| Disease | rostral middle frontal gyrus volume measurement | 5.84e-04 | 14 | 76 | 2 | EFO_0010328 | |
| Disease | Neurodevelopmental Disorders | 1.80e-03 | 93 | 76 | 3 | C1535926 | |
| Disease | Colorectal Carcinoma | 2.21e-03 | 702 | 76 | 7 | C0009402 | |
| Disease | cortical surface area measurement | PITPNM2 ANK3 MYCBP2 STAU2 VPS35L DGKI PAPPA AKAP10 QSER1 FMNL2 | 2.32e-03 | 1345 | 76 | 10 | EFO_0010736 |
| Disease | eye morphology measurement | 2.45e-03 | 218 | 76 | 4 | EFO_0007858 | |
| Disease | Retinitis Pigmentosa | 2.48e-03 | 104 | 76 | 3 | C0035334 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NKITTKKRSKSRSKE | 176 | Q13523 | |
| KKQSTLASSNKKSKV | 596 | Q6N043 | |
| RKASNTSKNISKAKQ | 691 | Q96QE3 | |
| KNNKKTSKNKSSLSR | 1551 | Q09472 | |
| TSKNKSSLSRGNKKK | 1556 | Q09472 | |
| RKVTTNKNATSISAK | 156 | Q0P641 | |
| SRSESQTKKLQAKVT | 951 | Q96M83 | |
| KKSTRVTKNKLRNTQ | 91 | Q8N157 | |
| QKSSVTSKTTRKGKE | 1311 | Q8N7X0 | |
| SQSSVKKASIKILKN | 546 | O43572 | |
| SSSSKKSKEQKALRL | 231 | Q8NFJ8 | |
| TIRQETTTKSKKSKK | 141 | P0DMQ9 | |
| LARKTSNEKSKVKSQ | 356 | A6NC57 | |
| KKTNKNKSSISRANK | 1591 | Q92793 | |
| TVKNRSKKSSKKANT | 21 | Q9Y2F9 | |
| KSQTLGSKSTTNEKK | 41 | Q5VSY0 | |
| SSSLRRSSKEKNKKN | 631 | Q5W041 | |
| TITTTSSKRKNRKNK | 1561 | O75179 | |
| TLTFSAQTKTSKAKK | 816 | O60610 | |
| GVSNTSRKTTKKQAK | 371 | Q9Y2E6 | |
| TKTSKSSKVKDLSTR | 621 | Q9ULK2 | |
| TNIQTQLSLKKKSTS | 741 | Q8WWL7 | |
| NVEASKNKSKTSTKL | 66 | Q9BWF3 | |
| YNKKTLRTSKTTTKS | 1641 | Q2KHR3 | |
| RKESSQSSTQSKEKK | 241 | O60870 | |
| STSVSQKQKRKTGTK | 636 | Q96NI6 | |
| ALLQSSASRKTQKKK | 356 | Q9UQ80 | |
| LISKSRETNLSKKKV | 416 | Q6ZWB6 | |
| ASKSLTTKTSKRRSK | 336 | Q8TDR0 | |
| KKALLALKKQSSSST | 26 | P18615 | |
| IKLLSSTKKKTSNNI | 1171 | Q3B7T1 | |
| KSSVGVKKNSKSRTL | 396 | Q4FZB7 | |
| TKLKKFQTGTRTKKS | 556 | Q9P266 | |
| TKKVSSSTNKNISAK | 5731 | Q5CZC0 | |
| KSKSKKRNSTQLKSR | 1296 | Q15154 | |
| LQQQSKVRKSRSKSK | 901 | Q86UK5 | |
| SSRKSKKRAFKTQCT | 1386 | Q13219 | |
| KKQWSTSSKSSRSSK | 301 | Q9BZ72 | |
| AISSSKKKELLKRQS | 2881 | Q8NCM8 | |
| KSAKSSIISKKKRQT | 796 | P46100 | |
| SIISKKKRQTQSESS | 801 | P46100 | |
| SQEKKTSLKRTSKTN | 286 | P0C671 | |
| AFTNSKKSVTLRKKT | 286 | Q13609 | |
| SSRKSTKKTNQSSKN | 556 | Q03188 | |
| TKKTNQSSKNIRKKT | 561 | Q03188 | |
| QNSLKASNRKKKRTS | 331 | O75912 | |
| SATLTKVKCAKRQKT | 51 | Q7Z4B0 | |
| TTTSCTVKVRKSQLK | 3976 | Q12955 | |
| IAASVSIKSSQKLKK | 806 | Q96PY5 | |
| LASQGSKKSKSSSKS | 136 | Q99750 | |
| KKLTKKTESQSQKRS | 2046 | Q8WYP5 | |
| KRIRTSKTKQASKNT | 2191 | Q8WYP5 | |
| TKQKKNQSLRTSAKS | 276 | Q58FG1 | |
| ARTSNAKTLKKAKSL | 841 | A5D8W1 | |
| KSKRTIQGTHKTTKQ | 51 | Q9BY12 | |
| SSKNTSKTKKHFSQL | 176 | Q32NC0 | |
| SSVASKKKKKSRQQA | 666 | P56715 | |
| SLSISKNKKKASNSI | 16 | Q9Y2M0 | |
| GLKLKKSLSKSTSQN | 426 | Q96PX1 | |
| TSKEIKKSKLIRSQS | 761 | Q6NUP7 | |
| KIKANRRSNSKKSKT | 231 | Q9NSI8 | |
| ISTNNKVSKSRKKSS | 1166 | Q5QGS0 | |
| RSCSVNNKVSKKTTK | 231 | Q5T036 | |
| RVTGSKKSTKRTKSI | 306 | Q8TCU6 | |
| KDKRISKTTKLNVSL | 21 | Q562F6 | |
| SKTTKLNVSLASKIK | 26 | Q562F6 | |
| SVRLKSNIRSTKSTK | 81 | Q9P0P8 | |
| SNIRSTKSTKKSLQK | 86 | Q9P0P8 | |
| KSKSKVKTRSKSENL | 116 | O75592 | |
| TVSIKSSKLLKTTSQ | 871 | Q75T13 | |
| KKASNLQKNKTASST | 451 | Q8IX21 | |
| SRNSTSVKKKSSRNI | 221 | Q15391 | |
| IRSKLKRTKQTATKT | 86 | Q8IY92 | |
| KRTKQTATKTKTLQG | 91 | Q8IY92 | |
| TFQKKKKTGSQTRRT | 16 | Q96A22 | |
| TQNVSTLSSKVKRKD | 86 | Q96HI0 | |
| TESKTKKVNRKGSTS | 41 | Q7Z3J2 | |
| QKAKKSSVSKRTQNK | 176 | P0CB47 | |
| SKKLSKKRAATTVLQ | 256 | Q9NUL3 | |
| SFSKRVQKSISQKKL | 46 | Q9HAJ7 | |
| INKKLTKQKSSSSIS | 646 | Q9BX26 | |
| SATQQKKNTKLSSKT | 41 | Q969T4 | |
| KKNTKLSSKTTAKLS | 46 | Q969T4 | |
| QSDKKRKFTTKSKSN | 1471 | O14795 | |
| VKVVSKFSNSNKRKT | 151 | Q15928 | |
| IKTTNVKSASRQKTS | 191 | Q96N95 | |
| QAKLASLRKSTKKRS | 296 | Q14669 |